Year None20252024202320222021202020192018 07 Jan '25 Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia 06 Jan '25 Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules 03 Jan '25 Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
07 Jan '25 Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia
06 Jan '25 Bionano Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
03 Jan '25 Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules